4//SEC Filing
Thompson Peter A. 4
Accession 0001415889-25-018387
CIK 0001671858other
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 4:30 PM ET
Size
6.2 KB
Accession
0001415889-25-018387
Insider Transaction Report
Form 4
Thompson Peter A
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-25+30,000→ 30,000 totalExercise: $17.26Exp: 2035-06-24→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]The shares subject to the option will vest in full on the earlier of June 25, 2026 or the date of the Issuer's 2026 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors.
- [F2]Pursuant to an agreement with OrbiMed Advisors LLC and OrbiMed Capital GP VI LLC, the Reporting Person is obligated to transfer any securities issued under any such stock options or other awards, or the economic benefit thereof, to OrbiMed Advisors LLC and OrbiMed Capital GP VI LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments VI, LP.
Documents
Issuer
ARS Pharmaceuticals, Inc.
CIK 0001671858
Entity typeother
Related Parties
1- filerCIK 0001357522
Filing Metadata
- Form type
- 4
- Filed
- Jun 26, 8:00 PM ET
- Accepted
- Jun 27, 4:30 PM ET
- Size
- 6.2 KB